Clinical trial identifies potential new treatment for liver disease

by

Researchers at the University of California San Diego School of Medicine have led a study to examine a potential new treatment option for patients with non-alcoholic steatohepatitis (NASH)-related fibrosis.

Leave A Comment

Your email address will not be published. Required fields are marked *